Publications
5600 Results
- Journal / Conference
- American Society of Hematology Annual Meeting (Dec 5-8, Orlando, FL), poster;
- Year
- 2015
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0806
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large b-cell lymphoma (DLBCL): SWOG S0806
- Journal / Conference
- Blood 126(23):2569; American Society of Hematology Annual Meeting (Dec 5-8, 2015, Orlando, FL), poster;
- Year
- 2015
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106
Effect of minimal residual disease (MRD) information on prediction of relapse and survival in adult acute myeloid leukemia (SWOG S0106)
- Journal / Conference
- Blood 126(23):2576; American Society of Hematology Annual Meeting (Dec 5-8, 2015, Orlando, FL), poster;
- Year
- 2015
- Research Committee(s)
- Leukemia and Molecular Epidemiology
- Study Number(s)
- S0106
Defining the genomic make up of acute myeloid leukemia in adolescents and young Adults (AYA) – report from COG AAML03P1, AAML531 and SWOG S0106
- Journal / Conference
- Blood 126(23):1308; American Society of Hematology Annual Meeting (Dec 5-8, 2015, Orlando, FL), poster;
- Year
- 2015
- Research Committee(s)
- Leukemia
- Study Number(s)
- CTSU/E2902
Tipifarnib as maintenance therapy In acute myeloid leukemia (AML) improves survival in women with high risk disease. Results of the phase III intergroup trial E2902
- Journal / Conference
- Blood 126(23):217; American Society of Hematology Annual Meeting (Dec 5-8, 2015, Orlando, FL), oral presentation;
- Year
- 2015
- Research Committee(s)
- Leukemia
- Study Number(s)
- CTSU/E2906
Phase III randomized trial of clofarabine as induction and post-remission therapy vs. standard daunorubicin & cytarabine induction and intermediate dose cytarabine post-remission therapy, followed by decitabine maintenance vs. observation in newly-diagnosed acute myeloid leukemia in older adults (Age>/=60 Years): A trial of the ECOG-ACRIN Cancer Research Group (E2906)
- Journal / Conference
- Blood 126(23):688; American Society of Hematology Annual Meeting (Dec 5-8, 2015, Orlando, FL), oral presentation;
- Year
- 2015
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9333, SWOG-9500, S9918
Prognostic methylation markers for survival in cytogenetically normal AML patients treated on SWOG trials
- Journal / Conference
- Blood 126(23):342; American Society of Hematology Annual Meeting (Dec 5-8, Orlando, FL), oral;
- Year
- 2015
- Research Committee(s)
- Lymphoma
- Study Number(s)
- CTSU/9177
Risk-adapted low-intensity therapy in adults with Burkitt lymphoma: preliminary report of a multicenter prospective phase II study of DA-EPOCH-R
- Journal / Conference
- Blood 2015 126(23):2678; American Society of Hematology Annual Meeting (Dec 5-8, Orlando, FL), poster presentation;
- Year
- 2015
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0016
Genomic alterations important for the prognosis in patients with follicular lymphoma treated on SWOG Study S0016
- Journal / Conference
- Blood 126(23):1498; American Society of Hematology Annual Meeting (Dec 5-8, Orlando, FL), poster;
- Year
- 2015
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0816
Feasibility of interim PET-adapted therapy in HIV-positive patients with advanced Hodgkin Lymphoma (HL) – sub-analysis of SWOG S0816 phase 2 trial
- Journal / Conference
- Breast Cancer Research and Treatment Apr;150(3):605-611
- Year
- 2015
- Research Committee(s)
- Breast
- PMID
- PMID25833209
- PMC
- PMC Pending